RealTime eClinical Solutions Welcomes New CEO, Jeff Kozloff
RealTime eClinical Solutions, a prominent figure in clinical research software technology, has taken a significant step forward with the appointment of Jeff Kozloff as its Chief Executive Officer. Jeff is stepping into this pivotal role to navigate the company through its exciting next phase of growth and innovation.
Experience and Background of Jeff Kozloff
With over 25 years of leadership experience across various sectors, including pharmaceuticals and clinical software, Jeff's career is marked by remarkable achievements. Before joining RealTime, he played vital roles at Verilogue and TrialScope, successfully leading those companies through significant growth and facilitating strategic exits. His experience is complemented by his role as Chairman of the Board at ProofPilot, showcasing his depth of knowledge in the industry.
RealTime's Vision and Future Goals
In his inaugural remarks, Jeff expressed his enthusiasm to join RealTime at such a transformative period for both the company and the clinical research industry. He emphasized RealTime's robust platform and its established reputation for nurturing strong partnerships with sites, sponsors, and contract research organizations (CROs). He is committed to enhancing these partnerships and delivering increased value to customers while advancing innovative technologies to improve trial efficiency.
The Impact of Digital Transformation on Clinical Trials
As the industry undergoes a rapid digital transformation, there is a growing demand for integrated, intelligent platforms to streamline trial operations. RealTime's extensive eClinical suite combines various essential tools, such as Clinical Trial Management Systems (CTMS), eRegulatory solutions, eSource, and participant engagement systems, among others. These innovations make RealTime a preferred partner for clients seeking expedited trial activation, superior data quality, and smoother workflows.
Transitioning Leadership for Future Success
Jeff Kozloff succeeds former CEO Stephen Johnson, who guided the company through a period of expansive growth. Under Jeff's direction, the RealTime team is set to continue pushing the envelope on platform innovation and data intelligence, addressing the complete lifecycle of clinical trials.
Message from the Founder
Rick Greenfield, Founder and Chief Strategy Officer of RealTime, commented on Jeff's appointment, highlighting his ability to scale tech companies and his insightful understanding of the clinical research landscape. Rick believes that Jeff's leadership will align seamlessly with RealTime's mission to provide operational efficiency and predictability for customers.
Investments in Future Technologies
Under Jeff's guidance, RealTime is committed to advancing its offerings through sustained investments in workflow efficiencies, analytics, and interoperability. The company's dedication to enhancing collaboration among sites, site networks, academic medical centers, sponsors, and CROs will be pivotal.
About RealTime eClinical Solutions
RealTime eClinical Solutions stands at the forefront of eClinical technology, revolutionizing clinical trials with an all-inclusive platform designed for various stakeholders, including clinical research sites and sponsors. This platform facilitates the entire trial workflow—from award to execution. Its components include CTMS, eReg, eISF, eSource, and participant engagement solutions. The recent introduction of TrialAlign further cements RealTime's commitment to enhancing site selection, feasibility, and analytics.
Frequently Asked Questions
What led to the appointment of Jeff Kozloff as CEO?
Jeff was appointed due to his extensive leadership experience and success in growing technology companies in the healthcare sector.
How does RealTime plan to innovate under new leadership?
RealTime aims to deepen partnerships, enhance customer value, and advance technologies to make clinical trials more efficient.
What is the significance of RealTime's eClinical suite?
The eClinical suite is integral for improving trial management, data quality, and participant engagement throughout clinical studies.
Who did Jeff Kozloff succeed as CEO?
He succeeded Stephen Johnson, who played a crucial role in leading the company through growth and expansion.
What innovations has RealTime introduced recently?
RealTime has recently launched TrialAlign, a platform aimed at improving site selection and trial performance analytics.
